Spanish firm Grifols (MCE: GRF) has submitted a Biologics License Application (BLA) for its new potential fibrinogen treatment to the US Food and Drug Administration (FDA). Grifols claims that its ...

Atara Biotherapeutics ATRA is a nimble allogeneic ... Position Tab-cel is already marketed in the EU under the brand name, Ebvallo, by Atara’s partner Pierre Fabre Medicament under an exclusive ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Atara Biotherapeutics (ATRA) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates ...

Atara Biotherapeutics Inc. (ATRA ... Tab-cel, under the brand name Ebvallo, is approved in the European Union, the United Kingdom, and Switzerland as a monotherapy for the treatment of adult ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...